OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS

M&A Transactions

M&A Transaction Chart

Viridian publishes weekly data on M&A transactions in the Cannabis/CBD/Psychedelic industries. This data includes information about the buyer and seller (public/private, state/country location), deal size, deal structure (cash, stock, earn-out), pricing, share information, and deal implied valuation.

Week ended 10/06/2023

Week ended 10/06/2023

This Section is Only Available to Higher Tier Memberships

Please Purchase a Premium or Enterprise membership to see more.

M&A Transactions Commentary

Viridian publishes weekly insights on the M&A landscape in the Cannabis/CBD/Psychedelic industries. These insights typically highlight the most interesting/meaningful M&A transactions for that week, and commentary on market conditions, M&A deal structures, target regions for acquirers, and industry sectors ripe for consolidation.

Week ended 10/06/2023

  • The Most Interesting M&A Deal of the Week:
  • On October 4, 2023, Vext Science ( VEXT: CSE)(VEXTF: OTCQX), a $30M market cap cannabis company with integrated operations in Arizona and Ohio, announced the closing of its Appalachian Pharm Processing LLC acquisition, which will give it the right to acquire ownership of a dispensary in Columbus Ohio (subject to ownership transfer approval from the Ohio Board of Pharmacy).
  • The total consideration of $12.5 million was paid with $11M cash and $1.5M stock.
  • After the closing of Vext’s recently announced Ohio Expansion Transaction, the Company will have an operating cultivation facility, an operating manufacturing facility, and four retail dispensaries in Ohio.
  • Vext consistently ranks in the top ten of the U.S. MSOs with a market cap of over $20M

Week ended 10/06/2023

This is the MA basic

Additional content is available to Premium and Enterprise users. Please purchase a higher tier membership to see more.